Best practice in macroscopic examination of gastric resections
- PMID: 17675536
- DOI: 10.1136/jcp.2006.045559
Best practice in macroscopic examination of gastric resections
Abstract
Gastric cancer is one of the most common cancers worldwide, with a frequency that varies greatly across different geographic locations. Over recent decades there has been a marked increase in cancers of the oesophagogastric junction, but gastric cancers have shown a decrease in worldwide incidence. However, they still account for 3-10% of all cancer-related deaths. There has been a steady improvement in prognosis in countries such as Japan, predominantly due to screening programmes and early detection, but this has not been seen in Europe and North America. At present the only curative treatment for gastric cancer is complete surgical resection of the primary tumour, with appropriate lymphadenectomy. High quality histology reports are necessary to provide information on diagnosis, prognosis and future management. They can also be important with regard to research, audit and epidemiological studies. This review examines the evidence-based guidelines for macroscopic examination and block selection for gastric carcinomas, with a brief comment on new surgical techniques.
Similar articles
-
[Diagnosis of and therapy for gastric cancer--work-flow].Zentralbl Chir. 2009 Aug;134(4):362-74. doi: 10.1055/s-0029-1224534. Epub 2009 Aug 17. Zentralbl Chir. 2009. PMID: 19688686 Review. German.
-
[Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].Chirurgia (Bucur). 2008 Nov-Dec;103(6):635-42. Chirurgia (Bucur). 2008. PMID: 19274907 Romanian.
-
[Lymphadenectomy in surgery for cancers of the stomach and esophagus].J Chir (Paris). 2008 Dec;145 Spec no. 4:12S21-12S29. J Chir (Paris). 2008. PMID: 19194354 Review. French.
-
Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.Eur J Cancer. 2008 Jan;44(2):182-94. doi: 10.1016/j.ejca.2007.11.001. Eur J Cancer. 2008. PMID: 18093827
-
[Clinical and pathological prognostic factors for cancers of the esophagogastric junction].Zentralbl Chir. 2009 Sep;134(5):455-61. doi: 10.1055/s-0029-1224512. Epub 2009 Sep 15. Zentralbl Chir. 2009. PMID: 19757346 German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical